Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_1219 |
| Primary information | |
|---|---|
| B3PDB ID | b3pdb_1219 |
| Peptide Name | CGKRK-PEG-DSPE |
| PEPTIDE SEQUENCE (1-letter) | CGKRK |
| PEPTIDE SEQUENCE (3-letter) | NA |
| N-terminal modification | NA |
| C-terminal modification | NA |
| Chemical modification | NA |
| Peptide Length | 5 |
| Conformation | NA |
| Peptide Nature | NA |
| Source/Origin of peptide | Chemically synthesized |
| SMILES | NA |
| Cell Line | U87MG cells |
| In vitro CONCENTRATION | NA |
| In vitro METHOD | Fluorescent microscopy |
| In vitro RESULT | It exhibited enhanced transportation |
| ANIMAL MODEL | Mice |
| In vivo CONCENTRATION | NA |
| In vivo MODE OF DELIVERY | Intravenous |
| In vivo METHOD | Fluorescence imaging analysis |
| In vivo RESULT | It penetrated across the BBB to accumulate at tumor sites with the assistance of Bor and active glio |
| ACTION | CGKRK-PSNPs combined with borneol could improve the anti-glioma efficacy with the prolonged medium s |
| TRANSPORT TYPE | Transcytosis |
| SUBCELLULAR LOCALISATION | NA |
| COMBINATION | Combined with borneol |
| PHYSICAL CONDITION | Glioblastoma |
| RESPONSE | NA |
| RESULT | NA |
| LABEL | NA |
| PMID | 32425792 |